Literature DB >> 29307626

Histologic and immunohistochemical differences between hereditary and sporadic diffuse gastric carcinoma.

Hee Eun Lee1, Thomas C Smyrk1, Lizhi Zhang2.   

Abstract

We aimed to identify histopathologic features unique in hereditary diffuse gastric cancer (HDGC) by comparing with its sporadic counterpart (SDGC). 11 patients with confirmed CDH1 mutation who were found to have HDGC in a prophylactic total gastrectomy were collected. Median age of HDGC patients was 39 years (range 24-57). All HDGC cases had intramucosal signet ring cell carcinoma. Twenty-three invasive tumor foci from 7 patients with HDGC were available for ancillary studies, and we evaluated each focus separately. Almost all foci (20/23) showed two distinct tumor cell populations, namely, large signet ring cells and small signet ring cells. The large cells were located just beneath the surface epithelium and were positive for mucicarmine and pCEA, while the small cells were found in the deeper lamina propria and were mostly negative for mucicarmine and pCEA. A subset of small cells (6 foci from two resected stomachs) showed poorly differentiated morphology with p16 positivity. All other tumor cells with well-differentiated signet ring cell morphology were negative for p16. In contrast, 18 of 20 SDGCs were positive for p16. In addition, all HDGCs were negative for CDX2, while 19 of 20 SDGCs were positive. We propose that there are three distinct tumor cell populations in HDGC: well-differentiated large cells, well-differentiated small cells, and poorly differentiated small cells, and that the latter group with aberrant p16 expression may represents a more aggressive phenotype. The absence of CDX2 in HDGC suggests that it may develop along a carcinogenetic pathway different from that of SDGC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CDH1 mutation; CDX2; Gastric carcinoma; Hereditary diffuse gastric carcinoma; p16

Mesh:

Year:  2018        PMID: 29307626     DOI: 10.1016/j.humpath.2017.12.023

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

Review 1.  Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review.

Authors:  Giovanni Corso; Giacomo Montagna; Joana Figueiredo; Carlo La Vecchia; Uberto Fumagalli Romario; Maria Sofia Fernandes; Susana Seixas; Franco Roviello; Cristina Trovato; Elena Guerini-Rocco; Nicola Fusco; Gabriella Pravettoni; Serena Petrocchi; Anna Rotili; Giulia Massari; Francesca Magnoni; Francesca De Lorenzi; Manuela Bottoni; Viviana Galimberti; João Miguel Sanches; Mariarosaria Calvello; Raquel Seruca; Bernardo Bonanni
Journal:  Cancers (Basel)       Date:  2020-06-17       Impact factor: 6.639

Review 2.  Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.

Authors:  Shamshul Ansari; Boldbaatar Gantuya; Vo Phuoc Tuan; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

3.  Constructing and Validating a Pyroptosis-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival.

Authors:  Jingmin Xu; Ke Chen; Zhou Wei; Zixuan Wu; Xuyan Huang; Minjie Cai; Kai Yuan; Peidong Huang; Jing Zhang; Shuai Wang
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

4.  CDH1 Gene Mutation Hereditary Diffuse Gastric Cancer Outcomes: Analysis of a Large Cohort, Systematic Review of Endoscopic Surveillance, and Secondary Cancer Risk Postulation.

Authors:  Matthew G K Benesch; Stuart R Bursey; Andrew C O'Connell; Morag G Ryan; Carrie L Howard; Cecily C Stockley; Alexander Mathieson
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 5.  Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.

Authors:  Irene Gullo; Federica Grillo; Luca Mastracci; Alessandro Vanoli; Fatima Carneiro; Luca Saragoni; Francesco Limarzi; Jacopo Ferro; Paola Parente; Matteo Fassan
Journal:  Pathologica       Date:  2020-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.